Oui, les hommes ont un risque plus élevé de développer des tumeurs gastriques que les femmes.
SexeFacteurs de risqueNéoplasmes gastriques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de l'estomac : Questions médicales les plus fréquentes",
"headline": "Tumeurs de l'estomac : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs de l'estomac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-15",
"dateModified": "2026-02-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'estomac"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies de l'estomac",
"url": "https://questionsmedicales.fr/mesh/D013272",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de l'estomac",
"code": {
"@type": "MedicalCode",
"code": "D013272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.405.748"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'estomac",
"alternateName": "Stomach Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D013274",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alessandro Vanoli",
"url": "https://questionsmedicales.fr/author/Alessandro%20Vanoli",
"affiliation": {
"@type": "Organization",
"name": "Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, and IRCCS San Matteo Hospital, Pavia, Italy."
}
},
{
"@type": "Person",
"name": "Tetsuo Ushiku",
"url": "https://questionsmedicales.fr/author/Tetsuo%20Ushiku",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. usikut-tky@umin.ac.jp."
}
},
{
"@type": "Person",
"name": "Jason C Mills",
"url": "https://questionsmedicales.fr/author/Jason%20C%20Mills",
"affiliation": {
"@type": "Organization",
"name": "Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, USA; Department of Pathology & Immunology, Baylor College of Medicine, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, USA. Electronic address: Jason.Mills@bcm.edu."
}
},
{
"@type": "Person",
"name": "Monika Vyas",
"url": "https://questionsmedicales.fr/author/Monika%20Vyas",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Erika Hissong",
"url": "https://questionsmedicales.fr/author/Erika%20Hissong",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, New York Presbyterian/Weill Cornell Medical Center, New York NY, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Stomach encyclopedia: Combined single-cell and spatial transcriptomics reveal cell diversity and homeostatic regulation of human stomach.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37819756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.celrep.2023.113236"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38732067",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25094847"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38907304",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12920-024-01934-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incidental FAPI Localization in Benign Bone Lesions in a Case of Carcinoma Stomach.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37796175",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004837"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prebiotics and the Risk of Upper Digestive Tract and Stomach Cancers: The PrebiotiCa Study.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37468063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jand.2023.07.008"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies gastro-intestinales",
"item": "https://questionsmedicales.fr/mesh/D005767"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de l'estomac",
"item": "https://questionsmedicales.fr/mesh/D013272"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs de l'estomac",
"item": "https://questionsmedicales.fr/mesh/D013274"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs de l'estomac - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs de l'estomac",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs de l'estomac",
"description": "Comment diagnostique-t-on une tumeur de l'estomac ?\nQuels tests d'imagerie sont utilisés ?\nQuels marqueurs tumoraux sont associés ?\nQuels symptômes indiquent un besoin de diagnostic ?\nQuelle est l'importance de la biopsie ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs de l'estomac",
"description": "Quels sont les symptômes courants des tumeurs gastriques ?\nComment se manifeste une obstruction gastrique ?\nLes tumeurs gastriques causent-elles des saignements ?\nQuels signes indiquent une progression de la maladie ?\nLes symptômes varient-ils selon le type de tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs de l'estomac",
"description": "Comment peut-on prévenir les tumeurs de l'estomac ?\nLe dépistage est-il recommandé ?\nQuel rôle joue l'infection à Helicobacter pylori ?\nLes vitamines peuvent-elles aider à la prévention ?\nL'exercice physique a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs de l'estomac",
"description": "Quels sont les traitements pour les tumeurs gastriques ?\nQuand la chirurgie est-elle recommandée ?\nLa chimiothérapie est-elle efficace ?\nQuels effets secondaires des traitements sont courants ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs de l'estomac",
"description": "Quelles complications peuvent survenir ?\nComment la malnutrition est-elle liée aux tumeurs gastriques ?\nLes tumeurs gastriques peuvent-elles se propager ?\nQuels sont les risques de récidive ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs de l'estomac",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme influence-t-il le risque ?\nL'alimentation joue-t-elle un rôle ?\nLes antécédents médicaux influencent-ils le risque ?\nLe sexe a-t-il un impact sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013274#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur de l'estomac ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par endoscopie et biopsie, complété par des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie, l'échographie et la tomodensitométrie (TDM)."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le CA 19-9 et le CEA peuvent être utilisés pour surveiller les tumeurs gastriques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales persistantes, des nausées ou une perte de poids inexpliquée."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la biopsie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet de confirmer la nature maligne ou bénigne de la tumeur."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs gastriques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, nausées, vomissements et perte d'appétit."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une obstruction gastrique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des vomissements, des douleurs et une incapacité à manger."
}
},
{
"@type": "Question",
"name": "Les tumeurs gastriques causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des saignements internes, entraînant des vomissements de sang."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une progression de la maladie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une perte de poids rapide, une fatigue excessive et des douleurs croissantes peuvent indiquer une progression."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'une tumeur bénigne ou maligne."
}
},
{
"@type": "Question",
"name": "Comment peut-on prévenir les tumeurs de l'estomac ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'évitement du tabac et la réduction de l'alcool peuvent aider."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage est recommandé pour les personnes à risque élevé, comme celles avec des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'infection à Helicobacter pylori ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infection à Helicobacter pylori est un facteur de risque majeur pour le cancer gastrique."
}
},
{
"@type": "Question",
"name": "Les vitamines peuvent-elles aider à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que des niveaux adéquats de vitamines A et C peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique a-t-il un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie actif peut réduire le risque de développer des tumeurs gastriques."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour les tumeurs gastriques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie selon le stade."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée pour les tumeurs localisées et opérables."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour réduire la taille des tumeurs avant la chirurgie ou en traitement adjuvant."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements sont courants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte d'appétit et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements ciblés comme le trastuzumab sont disponibles pour certains types de tumeurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perforation de l'estomac, les saignements et la malnutrition."
}
},
{
"@type": "Question",
"name": "Comment la malnutrition est-elle liée aux tumeurs gastriques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition peut résulter de l'obstruction ou de la douleur lors de l'alimentation."
}
},
{
"@type": "Question",
"name": "Les tumeurs gastriques peuvent-elles se propager ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se propager à d'autres organes, comme le foie et les ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de récidive ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de récidive dépend du type de tumeur et de l'efficacité du traitement initial."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire incluant nutrition et soins palliatifs."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, l'infection à Helicobacter pylori et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque reconnu pour le cancer de l'estomac."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en sel et en aliments transformés augmente le risque de tumeurs gastriques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de gastrite chronique ou d'ulcères augmentent le risque de cancer gastrique."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont un risque plus élevé de développer des tumeurs gastriques que les femmes."
}
}
]
}
]
}
Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, USA; Department of Pathology & Immunology, Baylor College of Medicine, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, USA. Electronic address: Jason.Mills@bcm.edu.
Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: wangda0618@zju.edu.cn.
The stomach is an important digestive organ with various biological functions. However, because of the complexity of its cellular and glandular composition, its precise cellular biology has yet to be ...
Plexiform fibromyxoma (PF), also referred to as plexiform angiomyxoid myofibroblast tumor, is an exceedingly rare mesenchymal neoplasm primarily affecting the stomach. Herein, we present a case of PF ...
Collagen (COL) genes, play a key role in tumor invasion and metastasis, are involved in tumor extracellular matrix (ECM)-receptor interactions and focal adhesion pathways. However, studies focusing on...
The TCGA database was employed to retrieve the clinical features and RNA sequencing expression profiles of patients with STAD. We conducted an investigation to examine the expression disparities betwe...
The expression levels of COL4A1/2 were significantly upregulated, while COL4A5/6 were conspicuously downregulated in STAD. The survival analysis revealed that the upregulated COL4s indicated poorer ov...
COL4s could potentially serve as biomarkers for diagnosing and predicting the prognosis of STAD....
Recently developed radiolabeled FAPI (fibroblast-activation protein inhibitors) have attracted researcher's attention in diagnosing various tumors because of its high specificity and better tumor-to-b...
Fiber intake may lower digestive tract cancer risk, possibly by modulating the composition of gut microbiota. However, no data are available about the role of specific fiber fractions with prebiotic a...
The objective was to assess the association between prebiotic intake and the risk of cancers of the upper digestive tract and stomach....
Within the PrebiotiCa study, data were derived from a network of Italian case-control studies conducted between 1992 and 2009. Participants' usual diet was assessed using a food frequency questionnair...
Cases were patients admitted to major hospitals with incident histologically confirmed cancers; there were 946 cases of cancer of the oral cavity/pharynx, 198 of the nasopharynx, 304 of the esophagus,...
The outcomes were oral and pharyngeal, nasopharyngeal, esophageal, and stomach cancers....
The odds ratios and corresponding 95% CIs of the various cancers were derived using logistic regression models adjusted for major confounders and energy intake....
No association was observed between intake of prebiotics and risk of cancers of the oral cavity and pharynx, nasopharynx, and esophagus. High raffinose intake reduced stomach cancer risk (odds ratio f...
The current study does not support a major role of prebiotic fibers on selected upper digestive tract cancers. The association between high raffinose intake and reduced stomach cancer risk needs furth...
The incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP NEN) is increasing at a rapid pace and is becoming an increasingly important consideration in clinical care. Epidemiological data ...
Neuroendocrine neoplasms are classified according to the WHO classification based on morphological criteria into neuroendocrine tumors, neuroendocrine carcinomas, and mixed neuroendocrine-non-neuroend...
It has been reported that cadherin 6 (CDH6) upregulation is associated with enhanced epithelial-to-mesenchymal transition (EMT) in several types of solid tumor cells. The current study aimed to explor...
The immunogenic cell death (ICD) is a specific type of regulatory cell death (RCD), which induces adaptive immunity against antigens of dead cells. ICDs have received increasing attention for their po...
Hepatoid adenocarcinoma of the stomach (HAS) is a highly malignant and rare extrahepatic tumor. The prognosis is controversial because of its rarity and the lack of multi-center cohort studies, especi...
We retrospectively reviewed clinical data of one HAS patient treated at our institution in 2019 and of 252 patients reported between 1984 and 2020 in research databases....
Among these patients, 60.1% were > 60 years, 51% had lesions in the gastric antrum, and 51.0% (73/143) had the ulcerative lesion type. The preoperative elevated levels of serum alpha-fetoprotein (AFP)...
Liver metastasis was increasingly more likely with increasingly higher serum AFP, but the prognosis of HAS is not necessarily poor. Serum AFP level is an important prognostic indicator in HAS and shou...